InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Oliver Tracie. Director active across 1 company, notably Arrowhead Pharmaceuticals, INC.. Cumulatively, 4 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €510k. History available since 4 January 2023. The latest transaction was disclosed on 2 July 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Oliver Tracie is a declarant linked to Arrowhead Pharmaceuticals, INC. (XNAS), where he is Chief Commercial Officer. He has 4 filings in total, and within the 4 sampled filings the dominant transaction type is sell, with total sales of EUR 509718 between 2023-01-05 and 2024-07-03.